Latest Financial Disclosures News

Straker Ltd reports a solid FY25 performance marked by a strategic shift from legacy translation services to AI-powered language verification, underpinned by robust cash reserves and improved profitability.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Capstone 510 Copper Georgia Corp. has amended its revolving credit facility, increasing its size to $1 billion and extending the maturity date to May 2029, enhancing its financial flexibility for ongoing projects.

Sigma Healthcare has released its standalone annual and sustainability reports for the year ending January 2025, marking the final disclosures before its merger with Chemist Warehouse Group in February 2025.

DTI Group Ltd has announced a fully underwritten non-renounceable entitlement offer to raise approximately $2.69 million by issuing new shares at a discounted price of $0.006 each. The offer, backed by major shareholder Finico Pty Ltd, aims to strengthen the company’s balance sheet and repay existing debt.

Universal Biosensors reported a 6% increase in revenue for Q1 2025 but posted a net loss of A$3.84 million, with cash reserves sufficient only through Q3 2025, raising questions about its financial sustainability.

FleetPartners Group Limited reported a 2.6% revenue increase to $377 million for the half-year ended March 2025, while net profit after tax declined 5.3% to $34.5 million, reflecting operational headwinds from a major system upgrade.

Judo Capital Holdings clarifies its recent Q3 financial disclosures, affirming compliance with ASX rules while highlighting FY26 profit guidance as material information.

Aeris Resources has refinanced its environmental bonding and term debt facilities with Washington H. Soul Pattinson, boosting liquidity and extending debt maturity to support growth projects.

Healius Limited has announced a special fully franked dividend of AUD 0.413 per ordinary share, signaling confidence in its financial position despite the ongoing suspension of its Dividend Reinvestment Plan.

Papyrus Australia has issued a revised Appendix 4C for the March 2025 quarter, correcting the treatment of $527k in R&D expenditure previously reported as cash payments. This adjustment also impacts prior monthly and quarterly cash flow reports dating back to November 2024.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.